Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease.

The study recruited 40 male patients with mild to moderate COPD, aged 55 to 65 years, and excluded people needing supplemental oxygen, chest infection, pulmonary hypertension, cardiac disease, obesity, diabetes, or mental disorders, so the results may not apply to more severe or complex COPD patients. The randomization description says 40 patients were recruited but also says allocation was to 25 per group, so the number analysed is unclear. The outcomes were IL-6 and CD4+/CD8+ ratio, not exacerbation attacks, hospital admission, or mortality rates, so the paper does not show clinical benefit. Both groups received medical treatment and placebo of the other modality, so the effect of any single component cannot be separated. Follow-up was only before and after the 2-month intervention, so longer-term effects are unknown. The paper contains inconsistent group labels and reports significant comparisons as p>0.0001.

Do not read the improved IL-6 and CD4+/CD8+ ratio as proof that these treatments reduce COPD exacerbation attacks, hospital admission, or mortality rates. The study measured immune markers only, and both groups also received medical treatment.